NX-5948
NX-5948-203
Phase 3 small_molecule active
Quick answer
NX-5948 for B-cell Lymphoma is a Phase 3 program (small_molecule) at Nurix Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Nurix Therapeutics
- Indication
- B-cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active